Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03524222 · ClinicalTrials.gov registry record · NA
Home Hospital for Suddenly Ill Adults
A NA study of Heart Failure and Asthma, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 2
- Study locations
NCT03524222: Recruiting NA study of Heart Failure and Asthma, sponsored by Brigham and Women's Hospital.
NCT03524222 is a NA study of Heart Failure and Asthma that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 3,000 participants, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03524222, a NA study of Heart Failure and Asthma, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.
Conditions Studied
Interventions
- OTHER Home Hospitalization
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Brigham and Women's Faulkner Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2031-09 |
| Phase | NA |
What NCT03524222 shows while recruiting
NCT03524222 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher).
The record links to 9 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Home Hospitalization is the first listed.
NCT03524222 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03524222 about?
NCT03524222 is a clinical study titled "Home Hospital for Suddenly Ill Adults". The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improv...
What is the current status of trial NCT03524222?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2018-01-18. Estimated completion is 2031-09.
What conditions does trial NCT03524222 study?
This clinical trial studies the following conditions: Heart Failure, Asthma, COPD, Chronic Kidney Diseases, Infection.
What interventions are being tested in trial NCT03524222?
The interventions under investigation include: Home Hospitalization (OTHER).
Who is sponsoring clinical trial NCT03524222?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03524222 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03524222's enrollment target sits among peer trials
3,000 35th of 397 higher than 362 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI